Target intelligence / Profile preview

MicroRNA 1285-1 (miR-1285-1)

Target
miR-1285-1
Molecular classification
MicroRNA, Non-coding RNA, Gene regulator, Small RNA
01

Overview

MicroRNA 1285-1 (miR-1285-1) is a small, non-coding RNA belonging to the microRNA family. It functions primarily as a post-transcriptional regulator of gene expression by binding to complementary sequences in the 3' untranslated regions of target mRNAs, leading to mRNA degradation or inhibition of translation. In human cells, the mature form of miR-1285 (from either MIR1285-1 or its paralog MIR1285-2) is identical, and the miRNA has been implicated as a tumor suppressor. Specifically, miR-1285 is significantly downregulated in renal cell carcinoma (RCC), and restoration of its expression can inhibit cancer cell proliferation, migration, and invasion. One well-characterized direct target is transglutaminase 2 (TGM2), which is upregulated in cancer and associated with drug resistance and metastasis. The broad regulatory roles of miR-1285 suggest its importance for normal cellular function and its dysregulation in oncogenic processes[2][3].

Other names
hsa-mir-1285-1MIRN1285-1MIR1285-1MIR1285miR-1285hsa-miR-1285
02

Mechanism of action

Post-transcriptional repression of target mRNAs (e.g., binding 3'-UTRs and inhibiting translation or promoting degradation)

03

Biological functions

Gene expression regulationCell proliferationCell migrationCell invasionApoptosisTumor suppression
04

Disease associations

Cancer (notably renal cell carcinoma)Other (as role in additional diseases has not been extensively characterized)
05

Safety considerations

Since microRNAs regulate many genes, therapeutic modulation can have widespread off-target effects and unpredictable gene regulatory changes
06

Biomarkers

Potential biomarker for renal cell carcinoma and possibly other cancers due to its altered expression in tumors[2][3]

Beyond the preview

Go deeper on MicroRNA 1285-1 (miR-1285-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 1285-1 (miR-1285-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call